Location of Repository

Amelioration of Experimental Autoimmune Encephalomyelitis in C57BL/6 Mice by Photobiomodulation Induced by 670 nm Light

By Kamaldeen A. Muili, Sandeep Gopalakrishnan, Stacy L. Meyer, Janis T. Eells and Jeri-Anne Lyons
Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3265499
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Preview

    Citations

    1. (2008). A brief overview of photodynamic therapy in Europe.
    2. (2007). Activation of latent TGF-beta1 levels in laser-enhanced oral wound healing.
    3. (1994). Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice.
    4. (2007). An interferon-gamma-producing Th1 subset is the major source of IL17 in experimental autoimmune encephalomyelitis.
    5. (1995). Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate.
    6. (2001). Attenuation of infarct size in rats and dogs after myocardial infarction by low-energy laser irradiation.
    7. (2001). Axonal Injury in Multiple Sclerosis. In:
    8. (1987). Biostimulation of wound healing in vivo by a helium-neon laser.
    9. (2009). Biphasic Dose Response in Low Level Light Therapy.
    10. (2006). Clinical and experimental applications of NIR-LED photobiomodulation.
    11. (2008). Cytokine mRNA expression is decreased in the subplantar muscle of rat paw subjected to carrageenan-induced inflammation after low-level laser therapy. Photomedicine and Laser Surgery 26:
    12. Demidova TN (2006) Mechanisms of Low Level Light Therapy.
    13. (2002). Determining the role of cytokines in UV-induced immunomodulation.
    14. (2008). Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system.[see comment].
    15. (2001). Effect of NASA light-emitting diode (LED) irradiation on wound healing.
    16. (2003). Effect of NASA light-emitting diode irradiation on molecular changes for wound healing in diabetic mice.
    17. (2004). Experimental autoimmune encephalomyelitis in mice wiht a targeted deletion of the inducible nitric oxide synthase gene: increased T-helper 1 response.
    18. (2003). Flavonoids inhibit myelin phagocytosis by macrophages; a structureactivity relationship study.
    19. (2000). Glatiramer acetate (Copaxone) induces degenerate Th2-polarized immune responses in patients with multiple sclerosis.
    20. (2001). Glatiramer acetate and IFN-beta act on dendritic cells in multiple sclerosis.
    21. (2009). Immunohistochemical assessment of myofibroblasts and lymphoid cells during wound healing in rats subjected to laser photobiomodulation at 660 nm.
    22. (2005). Immunology of Multiple Sclerosis.
    23. (2001). Immunomodulating effects of extracorporeal photochemotherapy in rat experimental allergic encephalomyelitis.
    24. (1996). Inducible nitric oxide synthase gene expression and enzyme activity correlate with disease activity in adoptively-transferred murine EAE.
    25. (2007). Infrared Laser Therapy for Ischemic Stroke: A New Treatment
    26. (1996). Interferon beta-1b decreases the migration of T lymphocytes in vitro: Effects on matrix metalloproteinase-9.
    27. (1999). Interferon-beta inhibits activated leukocyte migration through human brain microvascular endothelial cell monolayer.
    28. (2001). Ligh-emitting diode treatment reverses the effect of TTX on cytochrome oxidase in neurons.
    29. (2000). Light and Immunomodulation.
    30. (2011). Low-level laser therapy activates NF-kB via generation of reactive oxygen species in mouse embyronic fibroblasts.
    31. (2006). Low-Level Laser Therapy Applied Transcranially to Rats After Induction of Stroke Significantly Reduces Long-Term Neurological Deficits.
    32. (2001). Lowenergy laser irradiation reduces formation of scar tissue after myocardial infarction in rats and dogs.
    33. (1990). Lymphocyte migration into Brain modelled in vitro: control by lymphocyte activation, cytokines, and antigen.
    34. (2006). Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclersosis patieints.
    35. (2005). Mitochondrial dysfunction plays a key role in progressive axonal loss in multiple sclerosis.
    36. (2006). Mitochondrial protein nitration primes neurodegeneration in experimental autoimmune encephalomyelitis.
    37. (2004). Mitochondrial Signal Transduction in Accelerated Wound and Retinal Healing by Near-Infrared Light Therapy.
    38. (2002). NASA light-emitting diodes for the prevention of oral mucositis in pediatric bone marrow transplant patients.
    39. (2007). Natalizumab (Tysabri) treatment for relapsing multiple sclerosis.
    40. (2009). Near infrared light protects cardiomyocytes from hypoxia and reoxygenation injury by a nitric oxide dependent mechanism.
    41. (2010). Near Infrared Light Reduces Oxidative Stress and Preserves Function in CNS Tissue Vulnerable to Secondary Degeneration Following Partial Transection of the Optic Nerve.
    42. (2008). Near-infrared light via light-emitting diode treatment is therapeutic against rotenone- and 1-methyl-4-phenylpyridinium ion-induced neurotoxicity.
    43. (2006). Near–Infrared Light Therapy for Retinitis Pigmentosa.
    44. (2005). Nitric-oxide-dependent and independent mechanisms of protection from CNS inflammation during Th1-mediated autoimmunity: evidence from EAE in iNOS KO mice.
    45. (2006). NOS2 regulates cytokine production and VLA-4 expression in experimental autoimmune encephalomyelitis.
    46. (2007). Pathogenesis of axonal and neuronal damage in multiple sclerosis. Neurology 68: S22–31; discussion S43–54.
    47. (1994). Phagocytic activity of macrophages and microglial cells during the course of acute and chronic relapsing experimental autoimmune encephalomyelitis.
    48. (2004). Photobiological modulation of cell attachment via cytochrome c oxidase.
    49. (2005). Photobiomodulation directly benefits primary neurons functionally inactivated by toxins: Role of cytochrome c oxidase.
    50. (2008). Photobiomodulation in the treateatment of retinal injury and retinal degenerative diseases. In:
    51. (2011). Photobiomodulation Protects the Retina from Light-Induced Photoreceptor Degeneration.
    52. (2002). Photopheresis affects the course of experimental allergic encephalomyelitis in Lewis rat.
    53. (2008). Pretreatment with near-infrared light via light-emitting diode provides added benefit against rotenone and MPP+ induced neurotoxicity.
    54. (1984). Prevention of experimental allergic encephalomyelitis (EAE) in the SJL/J mouse by whole body ultraviolet irradiation.
    55. (2007). Reactivation of JC virus and development of PML in patients with multiple sclerosis.
    56. (2005). Sodium channels contribute to microglia/macrophage activation and function in EAE and MS.
    57. (2003). Specificity of a third kind: reactive oxygen and nitrogen intermediates in cell signaling.
    58. (2007). Suppression of an established immune response by UVA– critical role for mast cells.
    59. (2007). Suppression of mitochondrial oxidative stress provides long-term neuroprotection in Experimental Autoimmune Encephalomyelitis.
    60. (1990). Suppression of the immune response to alloantigen by factors released from ultraviolet-irradiated keratinocytes.
    61. (1991). T-lymphocyte entry into the central nervous system.
    62. (1994). The clinical relevance of immunosuppression by UV irradiation.
    63. (2001). The history of photodetection and photodynamic therapy.
    64. (2005). The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice.
    65. (2011). The Nuts and Bolts of Low-level Laser (Light) Therapy. Annals of Biomedical Engineering.
    66. (2011). The role of antibodies in multiple sclerosis.
    67. (2000). The role of cytokines in UV-induced systemic immune suppression.
    68. (1997). The role of interleukin-4 in ultraviolet B lightinduced immunosuppression.
    69. (2002). The role of nitric oxide in multiple sclerosis.
    70. (2011). Therapeutic photobiomodulation: nitric oxide and a novel function of mitochondrial cytochrome c oxidase.
    71. (1996). Transcutaneous photodynamic therapy alters the development of an adoptively transferred form of murine experimental autoimmune encephalomyelitis.
    72. (2011). Tumor necrosis factor alpha (TNF-a), anti-TNF-a and demyelination revisited: An ongoing story.
    73. (2011). Waisman A

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.